surinenglish

National

Spanish medicines regulator recalls a batch of a drug used to treat heartburn

Aemps has ordered the withdrawal of the batch. File photograph.
Aemps has ordered the withdrawal of the batch. File photograph. / SUR

  • Rabeprazole Pensa is used to treat gastroesophageal reflux disease and stomach ulcers

  • SUSANA ZAMORA

The Spanish Agency for Medicines and Health Products (Aemps) has ordered the withdrawal of all units a batch of tablets used to treat heartburn and other conditions from the market.

The affected batch is 911064 of Rabeprazole Pensa 20 mg gastro-resistant tablets EFG, manufactured by Specifer SA and marketed by Pensa Pharma SAU, with an expiry date of 09/30/2021 - which is being recalled for being "out of specifications in stability studies."

The regulator has asked the autonomous regions to monitor the withdrawal of the tablets.

Rabeprazole is used to treat gastroesophageal reflux disease, ulcers in the stomach or upper intestine and Zollinger-Ellison syndrome.

According to the Drug Information Cente (Cima), these tablets belong to a group of drugs known as proton pump inhibitors, which work by reducing the amount of acid produced by the stomach.

Noticias relacionadas